Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Fajri Gafar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Pharmacokinetics and pharmacodynamics of high-dose isoniazid for the treatment of rifampicin- or multidrug-resistant tuberculosis in Indonesia
Yunivita, V., Gafar, F., Santoso, P., Chaidir, L., Soeroto, A. Y., Meirina, T. N., Te Brake, L., Menzies, D., Aarnoutse, R. E. & Ruslami, R., May-2024, In: The Journal of antimicrobial chemotherapy. 79, 5, p. 977-986 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access1 Citation (Scopus)30 Downloads (Pure) -
Pharmacokinetics of standard versus high-dose rifampin for tuberculosis preventive treatment: a sub-study of the 2R2 randomized controlled trial
Gafar, F., Yunivita, V., Fregonese, F., Apriani, L., Aarnoutse, R. E., Ruslami, R. & Menzies, D., Jul-2024, In: International journal of antimicrobial agents. 64, 1, 24 p., 107197.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis
Global Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in Pharmacokinetics of Anti-TB Drugs, Gafar, F., Wasmann, R. E., McIlleron, H. M., Aarnoutse, R. E., Schaaf, H. S., Marais, B. J., Agarwal, D., Antwi, S., Bang, N. D., Bekker, A., Bell, D. J., Chabala, C., Choo, L., Davies, G. R., Day, J. N., Dayal, R., Denti, P., Donald, P. R. & Engidawork, E. & 31 others, , 2023, In: European Respiratory Journal. 61, 23 p., 2201596.Research output: Contribution to journal › Review article › peer-review
Open AccessFile19 Citations (Scopus)188 Downloads (Pure) -
Is it time for new fixed-dose combinations and revised weight bands for children with drug-susceptible TB?
Gafar, F. & Alffenaar, J.-W. C., 1-May-2023, In: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 27, 5, p. 345-347 3 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)44 Downloads (Pure) -
TB therapeutic drug monitoring - analysis of opportunities in Romania and Ukraine
Margineanu, I., Butnaru, T., Gafar, F., Baiceanu, D., Dragomir, R., Semianiv, I., Mihaltan, F., Munteanu, I., Mahler, B., Todoriko, L., Margineanu, S., Akkerman, O., Stienstra, Y. & Alffenaar, J.-W. C., 1-Nov-2023, In: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 27, 11, p. 816-821 6 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile9 Downloads (Pure)
-
Risk factors of childhood TBM mortality and neurological morbidity in Indonesia
Gafar, F. (Invited speaker)
27-May-2022Activity: Talk and presentation › Academic presentation › Academic
-
Epidemiology and treatment outcomes of childhood and adolescent tuberculosis in the Netherlands
Gafar, F. (Invited speaker)
15-Jan-2021Activity: Talk and presentation › Professional or public presentation › Professional